Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial

Sherborne, AL, Shah, V, Ellis, S et al. (15 more authors) (2017) Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial. In: Blood. 59th ASH Annual Meeting and Exposition, 09-12 Dec 2017, Atlanta, GA, USA. American Society of Hematology , p. 1767.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 by The American Society of Hematology. This is an author produced version of a paper published in Blood. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 7 December 2017
  • Accepted: 2 August 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
?? Leeds.SU-LI55 ??
?? Leeds.SU-LI06 ??
Depositing User: Symplectic Publications
Date Deposited: 18 Dec 2018 15:12
Last Modified: 18 Dec 2018 15:31
Status: Published
Publisher: American Society of Hematology
Related URLs:

Share / Export